Evidence map›Paper›PMID 19159451›Full record

ArticleBMC molecular biology2009

Identification of novel Bach2 transcripts and protein isoforms through tagging analysis of retroviral integrations in B-cell lymphomas.

Jinghua Liu, Annette Balle Sørensen, Bruce Wang, Matthias Wabl, Anders Lade Nielsen, Finn Skou Pedersen

Open access · hybridAbstract read
In one paragraph

Article in BMC molecular biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. IKAROS in Acute Leukemia: A Positive Influencer or a Mean Hater?International journal of molecular sciences · 2023
    Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Jinghua LiuDepartment of Molecular Biology, C.F. Møllers Allé 1.130, University of Aarhus, Aarhus C, Denmark. jul@mb.au.dk
Annette Balle Sørensen
Bruce Wang
Matthias Wabl
Anders Lade Nielsen
Finn Skou Pedersen
Aarhus University · DKCollaborative Drug Discovery (United States) · USState and University Library · DKUniversity of California, San Francisco · US

Funding

Tumor Suppressors in LymphocytesR01CA100266 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WABL, MATTHIAS R · 2006 to 2008
$802k
NCI NIH HHS R01 CA100266
6 · The paper itself

Abstract

backgroundThe Bach2 gene functions as a transcriptional repressor in B-cells, showing high expression level only before the plasma cell stage. Several lines of evidence indicate that Bach2 is a B-cell specific tumor suppressor. We here address patterns of insertional mutagenesis and expression of Bach2 is a murine retroviral model of B-cell lymphoma induction.

resultsWe report that the Bach2 gene is a target of proviral integrations in B-cell lymphomas induced by murine leukemia virus. An alternative Bach2 promoter was identified within intron 2 and this promoter was activated in one of the tumors harboring proviral integration. The alternative promoter was active in both normal and tumor tissue and the tissue specificity of the two Bach2 promoters was similar. Three different alternatively used Bach2 terminal exons were identified to be located in intron 4. The inclusion of these exons resulted in the generation of Bach2 mRNA with open reading frames lacking the bZIP DNA binding domain present in the normal Bach2 protein, but retaining a partial BTB protein dimerization domain. Such Bach2 protein was excluded from the cell nucleus.

conclusionWe have identified an alternative promoter and new protein isoforms of Bach2. Our data imply that activation of an alternative promoter by proviral integration serves as a possible mechanism of up-regulation of the Bach2 gene with a potential role in B-cell lymphomagenesis. The finding of novel Bach2 transcripts and protein isoforms will facilitate a better insight into the normal and pathophysiological regulation of the Bach2 gene.

Indexed as

Alternative SplicingVirus IntegrationAnimalsBase SequenceBasic-Leucine Zipper Transcription FactorsCell LineGenetic VectorsHumansLeukemia Virus, MurineLymphoma, B-CellMiceMice, Inbred StrainsMolecular Sequence DataMutagenesis, InsertionalPromoter Regions, GeneticProtein IsoformsBach2 protein, mouseBasic-Leucine Zipper Transcription FactorsProtein Isoforms

Identifiers

PMID19159451
PMCPMC2635362
OpenAlexW2052076047

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.